Company profile: Therapak
1.1 - Company Overview
Company description
- Provider of diagnostic and medical device kitting services for clinical trials and healthcare, including protocol management, kit development, global distribution, and configurable collection kits, supported by PASSPORT online systems. Offers clinical supply packaging for temperature-sensitive shipments, specialized specimen collection and transport products, including customizable test-specific kits and temperature-controlled shipping systems, and an online hazardous materials training course.
Products and services
- Diagnostic Kitting Services: Delivers configurable diagnostic specimen collection kits and bulk supplies with global shipping and tracking through the PASSPORT™ CSE system, PASSPORT™ CSE-integrated
- Drug Development Kitting Services: Architects clinical trial kits with protocol management, kit development, and global distribution supported by the PASSPORT™ online system, global-scale
- Medical Device Kitting Services: Develops and distributes custom kits for the medical device industry, including recovery and diagnostic kits, using the PASSPORT™ online portal, custom-built
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Therapak
TD2
HQ: United States
Website
- Description: Provider of oncology-focused contract research services, offering data-driven clinical study management for Phase I–III trials; preclinical tools with 400+ cancer models to maximize data value and predict patient response; regulatory support (IND readiness, development, filings, FDA interactions); PK/ADME assays; and CDX models including NCI-H1963 (lung) and CCRF-CEM (T-ALL) to accelerate translational oncology.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full TD2 company profile →
Jennewein Biotech
HQ: Germany
Website
- Description: Provider of industrial biotechnology solutions specializing in developing processes for the identification, characterization, and production of scarce, functional monosaccharides and oligosaccharides, with a focus on sugar molecules offering attractive health benefits.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Jennewein Biotech company profile →
CPH
HQ: Switzerland
Website
- Description: Provider of chemical manufacturing and paper and packaging products for the chemical industries, serving the chemistry, paper, and packaging sectors.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CPH company profile →
INCOG BioPharma Services
HQ: United States
Website
- Description: Provider of injectable drug product services, including formulation development, analytical method development, process scale up, and formulation/filling of vials, syringes, and cartridges for clinical and commercial manufacturing. Offers QC chemistry and microbiology testing, inspection, labeling, packaging, device assembly, and material/finished product storage.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full INCOG BioPharma Services company profile →
Open Health
HQ: United Kingdom
Website
- Description: Provider of medical communications, omni, HEOR, and market access services, including market access strategy; health economic modeling and meta-analysis; patient engagement; patient-centered outcomes; real-world evidence and data analytics; medical affairs consultancy and strategy; publications planning and delivery; scientific communications; and learning and development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Open Health company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Therapak
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Therapak
2.2 - Growth funds investing in similar companies to Therapak
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Therapak
4.2 - Public trading comparable groups for Therapak
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →